Email:
Phone:

Azido-PEG4-Val-Cit-PAB-MMAE

Cat No.: BADC-02038 4.5

Azido-PEG4-Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC with the tubulin inhibitor MMAE. It consists of an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups.

Azido-PEG4-Val-Cit-PAB-MMAE

Structure of 1869126-64-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support

Category

ADC Cytotoxin with Linker

Molecular Formula

C69H113N13O17

Molecular Weight

1396.71

Storage

Store at -20 °C

* For research and manufacturing use only. We do not sell to patients.

Size	Price	Stock	Quantity
--	$--	In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Delivery of 200+ ADCs annually;
mg to g scale for early stage;
4,000 m² cGMP facilities;
CDMO and CMO support.

24/7 customer service;
100% quality assurance;
Efficient global delivery;
Over 95% customer satisfaction.

Popular Publications Citing BOC Sciences Products

Product Information
QA & Reviews

IUPAC Name

[4-[[(2S)-2-[[(2S)-2-[3-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methyl N-[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methylcarbamate

SMILES

CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)OCC3=CC=C(C=C3)NC(=O)[C@H](CCCNC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)CCOCCOCCOCCOCCN=[N+]=[N-]

InChI

InChI=1S/C69H113N13O17/c1-15-46(8)60(54(93-13)41-56(84)82-32-20-24-53(82)62(94-14)47(9)63(86)74-48(10)61(85)50-21-17-16-18-22-50)80(11)67(90)58(44(4)5)78-66(89)59(45(6)7)81(12)69(92)99-42-49-25-27-51(28-26-49)75-64(87)52(23-19-30-72-68(70)91)76-65(88)57(43(2)3)77-55(83)29-33-95-35-37-97-39-40-98-38-36-96-34-31-73-79-71/h16-18,21-22,25-28,43-48,52-54,57-62,85H,15,19-20,23-24,29-42H2,1-14H3,(H,74,86)(H,75,87)(H,76,88)(H,77,83)(H,78,89)(H3,70,72,91)/t46-,47+,48+,52-,53-,54+,57-,58-,59-,60-,61+,62+/m0/s1

InChIKey

PDBSIBYOBPJSRL-SFLKBQQHSA-N

Appearance

White to off-white solid

Storage

Store at -20 °C

Molarity Calculator
Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass

Concentration

Volume

Molecular Weight *

Calculate

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

C1

Volume _(start)

V1

Concentration _(final)

C2

Volume _(final)

V2

Calculate

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

In Stock Purity: 95% Hot

Fmoc-Val-Ala-PAB-PFP

Fmoc-Val-Ala-PAB-PFP

CAS: 2348406-01-7

In Stock Purity: >95% Hot

CAS: 163515-35-3

In Stock Purity: 90% Hot

N-Me-L-Ala-maytansinol

N-Me-L-Ala-maytansinol

CAS: 77668-69-0

In Stock Purity: 95% Hot

CAS: 1026987-94-9

Mc-Val-Cit-PAB-Cl

Mc-Val-Cit-PAB-Cl

CAS: 1639351-92-0

CAS: 1279680-68-0

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Payload Development Biological Payload ADC Linker–Payload Conjugation ADC Linker Development Chemical Payload Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Maytansine and Its Analogues Linkers - A Crucial Factor in Antibody–Drug Conjugates Cytotoxic Agents Used in Antibody–Drug Conjugates Exatecan Mesylate in ADCs: A New Topo I Inhibitor What is Calicheamicin? What is Monomethyl Auristatin E (MMAE)? What is Monomethyl Auristatin F (MMAF)? What is Pyrrolobenzodiazepine (PBD)? Antiviral Potential of Thapsigargin in COVID-19 Research In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC Cytotoxin with Linker

ADC Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug Conjugates (ADCs)

Antibody-Drug Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: DBCO-PEG4-vc-PAB-Duocarmycin TM | DBCO-PEG4-DMEA-PNU159682 | NH2-PEG3-DMEA-PNU159682 | Mc-Dexamethasone | DL-01 formic | Deruxtecan | DBCO-PEG4-VC-PAB-DMEA-((S)-Seco-Duocarmycin SA) | Mal-PEG2-VCP-Eribulin | MP-PEG4-VK(Boc)G-OSu | CCK2R Ligand-Linker Conjugates 1 | Azido-PEG4-Val-Cit-PAB-MMAE

Send Inquiry

Verification code

Great Minds Choose BOC Sciences

Inquiry Basket

Loading......

Go to checkout